Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 8(1): 5241, 2018 Mar 22.
Article in English | MEDLINE | ID: mdl-29568031

ABSTRACT

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

2.
PLoS One ; 12(10): e0186505, 2017.
Article in English | MEDLINE | ID: mdl-29049397

ABSTRACT

The Mycobacterium tuberculosis protein encoded by the Rv1986 gene is a target for memory T cells in patients with tuberculosis, and shows strong similarities to a lysine exporter LysE of Corynebacterium glutamicum. During infection, the pathogen Mycobacterium tuberculosis adapts its metabolism to environmental changes. In this study, we found that the expression of Rv1986 is controlled by Rv1985c. Rv1985c is located directly upstream of Rv1986 with an overlapping promoter region between both genes. Semiquantitative reverse transcription PCR using an isogenic mutant of Mycobacterium tuberculosis lacking Rv1985c showed that in the presence of lysine, Rv1985c protein positively upregulated the expression of Rv1986. RNA sequencing revealed the transcription start points for both transcripts and overlapping promoters. An inverted repeat in the center of the intergenic region was identified, and binding of Rv1985c protein to the intergenic region was confirmed by electrophoretic mobility shift assays. Whole transcriptome expression analysis and RNAsequencing showed downregulated transcription of ppsBCD in the Rv1985c-mutant compared to the wild type strain. Taken together, our findings characterize the regulatory network of Rv1985c in Mycobacterium tuberculosis. Due to their similarity of an orthologous gene pair in Corynebacterium glutamicum, we suggest to rename Rv1985c to lysG(Mt), and Rv1986 to lysE(Mt).


Subject(s)
Bacterial Proteins/metabolism , Lysine/metabolism , Mycobacterium tuberculosis/metabolism , Trans-Activators/metabolism , Amino Acid Sequence , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Electrophoretic Mobility Shift Assay , Gene Expression Regulation, Bacterial , Genes, Bacterial , Mycobacterium tuberculosis/genetics , Promoter Regions, Genetic , Reverse Transcriptase Polymerase Chain Reaction , Sequence Homology, Amino Acid , Trans-Activators/chemistry , Trans-Activators/genetics , Transcriptome
3.
Mol Microbiol ; 106(4): 530-542, 2017 Nov.
Article in English | MEDLINE | ID: mdl-28898511

ABSTRACT

Gas vesicles are proteinaceous, gas-filled nanostructures produced by some bacteria and archaea. The hydrophobic major structural protein GvpA forms the ribbed gas vesicle wall. An in-silico 3D-model of GvpA of the predicted coil-α1-ß1-ß2-α2-coil structure is available and implies that the two ß-chains constitute the hydrophobic interior surface of the gas vesicle wall. To test the importance of individual amino acids in GvpA we performed 85 single substitutions and analyzed these variants in Haloferax volcanii ΔA + Amut transformants for their ability to form gas vesicles (Vac+ phenotype). In most cases, an alanine substitution of a non-polar residue did not abolish gas vesicle formation, but the replacement of single non-polar by charged residues in ß1 or ß2 resulted in Vac- transformants. A replacement of residues near the ß-turn altered the spindle-shape to a cylindrical morphology of the gas vesicles. Vac- transformants were also obtained with alanine substitutions of charged residues of helix α1 suggesting that these amino acids form salt-bridges with another GvpA monomer. In helix α2, only the alanine substitution of His53 or Tyr54, led to Vac- transformants, whereas most other substitutions had no effect. We discuss our results in respect to the GvpA structure and data available from solid-state NMR.


Subject(s)
Haloferax volcanii/metabolism , Proteins/genetics , Proteins/metabolism , Amino Acid Sequence/genetics , Archaeal Proteins/metabolism , Bacterial Outer Membrane Proteins/metabolism , Genes, Bacterial/genetics , Mutation , Proteins/chemistry
4.
Sci Rep ; 7(1): 6484, 2017 07 25.
Article in English | MEDLINE | ID: mdl-28744015

ABSTRACT

Mycobacterium tuberculosis (Mtb) uses alveolar macrophages as primary host cells during infection. In response to an infection, macrophages switch from pyruvate oxidation to reduction of pyruvate into lactate. Lactate might present an additional carbon substrate for Mtb. Here, we demonstrate that Mtb can utilize L-lactate as sole carbon source for in vitro growth. Lactate conversion is strictly dependent on one of two potential L-lactate dehydrogenases. A knock-out mutant lacking lldD2 (Rv1872c) was unable to utilize L-lactate. In contrast, the lldD1 (Rv0694) knock-out strain was not affected in growth on lactate and retained full enzymatic activity. On the basis of labelling experiments using [U-13C3]-L-lactate as a tracer the efficient uptake of lactate by Mtb and its conversion into pyruvate could be demonstrated. Moreover, carbon flux from lactate into the TCA cycle, and through gluconeogenesis was observed. Gluconeogenesis during lactate consumption depended on the phosphoenolpyruvate carboxykinase, a key enzyme for intracellular survival, showing that lactate utilization requires essential metabolic pathways. We observed that the ΔlldD2 mutant was impaired in replication in human macrophages, indicating a critical role for lactate oxidation during intracellular growth.


Subject(s)
Lactic Acid/chemistry , Macrophages/microbiology , Mycobacterium tuberculosis/growth & development , Mycobacterium tuberculosis/metabolism , Pyruvic Acid/chemistry , Tuberculosis/microbiology , Carbon Cycle , Cells, Cultured , Gluconeogenesis , Humans , L-Lactate Dehydrogenase/genetics , L-Lactate Dehydrogenase/metabolism , Lactic Acid/metabolism , Macrophages/metabolism , Macrophages/pathology , Oxidation-Reduction , Pyruvic Acid/metabolism , Tuberculosis/pathology
5.
Mar Drugs ; 14(1): 21, 2016 Jan 20.
Article in English | MEDLINE | ID: mdl-26805858

ABSTRACT

In this study, the influence of halide ions on [7.7]paracyclophane biosynthesis in the cyanobacterium Nostoc sp. CAVN2 was investigated. In contrast to KI and KF, supplementation of the culture medium with KCl or KBr resulted not only in an increase of growth but also in an up-regulation of carbamidocyclophane production. LC-MS analysis indicated the presence of chlorinated, brominated, but also non-halogenated derivatives. In addition to 22 known cylindrocyclophanes and carbamidocyclophanes, 27 putative congeners have been detected. Nine compounds, carbamidocyclophanes M-U, were isolated, and their structural elucidation by 1D and 2D NMR experiments in combination with HRMS and ECD analysis revealed that they are brominated analogues of chlorinated carbamidocyclophanes. Quantification of the carbamidocyclophanes showed that chloride is the preferably utilized halide, but incorporation is reduced in the presence of bromide. Evaluation of the antibacterial activity of 30 [7.7]paracyclophanes and related derivatives against selected pathogenic Gram-positive and Gram-negative bacteria exhibited remarkable effects especially against methicillin- and vancomycin-resistant staphylococci and Mycobacterium tuberculosis. For deeper insights into the mechanisms of biosynthesis, the carbamidocyclophane biosynthetic gene cluster in Nostoc sp. CAVN2 was studied. The gene putatively coding for the carbamoyltransferase has been identified. Based on bioinformatic analyses, a possible biosynthetic assembly is discussed.


Subject(s)
Anti-Bacterial Agents/biosynthesis , Cyanobacteria/metabolism , Ethers, Cyclic/metabolism , Culture Media , Fluorides/pharmacology , Humans , Potassium Compounds/pharmacology , Potassium Iodide/pharmacology , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...